Sign in
4

Changes in Ownership

MANNKIND CORP Filed Acc 0001209191-22-028679

EVP Endocrine Business Unit acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Galindo Alejandro · EVP Endocrine Business Unit

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2022-05-10 Grant or award : show line 1 in the form +90,000 666,690 D
2022-05-10 Grant or award : show line 2 in the form +110,000 776,690 D
Loading xslF345X03/doc4.xml…